Craig Rohan is a Dermatology physician. OpenAlex indexes 49 publications with 358 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4881 Sugar Maple Dr Dept Of
Wright Patterson Afb, OH 454335529
Telephone
937-257-1574Registry record last updated 6 Apr 2018.
Clinical trials
- The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
Sponsor: Wright State University
- Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli
Sponsor: Wright State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB SAProgram year202513 payments
- Novartis Pharmaceuticals CorporationProgram year20254 payments
- Janssen Research & Development, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
33.7%RNA Synthetase Inhibitor Antibacterial14.1%Mupirocin100%Part D≥142 patientsCorticosteroid11.9%Mometasone Furoate100%Part D≥131 patients+ 3 more classes in this area
Anti-infectives
22%Azole Antifungal14.1%Ketoconazole96%Fluconazole4%Part D<11 patientsTetracycline-class Drug4.8%Doxycycline Hyclate80%Minocycline Hcl20%Part D<11 patients+ 3 more classes in this area
Sensory organs
13.5%Corticosteroid13.5%Clobetasol Propionate69%Dexamethasone11%Hydrocortisone11%Desonide5%Betamethasone Dipropionate4%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2025–2025 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Novel Histopathologic Features of Diffuse Blue‐Gray Hyperpigmentation Associated With Kratom Use: A Case Report and Literature Review
Journal of Cutaneous Pathology
2026 - Immunomodulatory effects of photodynamic therapy for skin cancer: Potential strategies to improve treatment efficacy and tolerability
Photochemistry and Photobiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”